Literature DB >> 9605807

Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers.

P Osin, T Crook, T Powles, J Peto, B Gusterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9605807     DOI： 10.1016/S0140-6736(98)24020-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer.

Authors:  S R Lakhani
Journal:  Mol Pathol       Date:  2001-10

Review 2.  Chemoprevention of breast cancer: implications for postmenopausal women.

Authors:  Carol J Fabian; Bruce F Kimler
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  Breast cancer prevention trials.

Authors:  D J Rhodes; L C Hartmann; E A Perez
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

4.  Familial breast cancer: an investigation into the outcome of treatment for early stage disease.

Authors:  D Eccles; P Simmonds; J Goddard; M Coultas; S Hodgson; F Lalloo; G Evans; N Haites
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

Review 5.  The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?

Authors:  D Bertwistle; A Ashworth
Journal:  Breast Cancer Res       Date:  1999-10-27       Impact factor: 6.466

Review 6.  The pathology of familial breast cancer: Immunohistochemistry and molecular analysis.

Authors:  P P Osin; S R Lakhani
Journal:  Breast Cancer Res       Date:  1999-10-27       Impact factor: 6.466
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.